[ad_1] The human body is an intricate system where diseases that seem unrelated at first glance can share deep-rooted connections, often through genetics. Congenital heart disease (CHD) and Alzheimer’s disease (AD) may appear worlds apart—one is a structural problem of the heart present at birth, while the other is a neurodegenerative disorder that emerges with … Read more
[ad_1] Hannah Yoon | The Washington Post | Getty Images Leqembi, an Alzheimer’s drug from Biogen and Eisai, isn’t a cure for the mind-damaging disease. But the treatment promises to give patients such as Missie Meeks more time to live their daily lives normally and independently of others. Meeks, an English professor based in Ellisville, … Read more
[ad_1] GE Healthcare on Wednesday morning reported a mixed second quarter and shares initially moved sharply lower. The stock then reversed higher as the post-earnings call got underway. Management made it clear that they think that weakness in China is temporary and see many other levers available to grow earnings. Revenue advanced less than 1% year … Read more
[ad_1] The Food and Drug Administration approved a new Alzheimer’s treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of drugs aimed at slowing the brain’s decline in patients facing the early stages of the disease. Branded as Kisunla by drugmaker Eli Lilly, donanemab’s approval follows years of … Read more
